These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19743227)

  • 21. Acute effects of inhaled menthol on the rewarding effects of intravenous nicotine in smokers.
    Valentine GW; DeVito EE; Jatlow PI; Gueorguieva R; Sofuoglu M
    J Psychopharmacol; 2018 Sep; 32(9):986-994. PubMed ID: 29788802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.
    Rose JE; Behm FM; Westman EC
    Pharmacol Biochem Behav; 2001 Feb; 68(2):187-97. PubMed ID: 11267622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine.
    Sofuoglu M; Herman AI; Nadim H; Jatlow P
    Neuropsychopharmacology; 2012 May; 37(6):1509-16. PubMed ID: 22334123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans.
    Sofuoglu M; Waters AJ; Mooney M; O'Malley SS
    Pharmacol Biochem Behav; 2009 Mar; 92(1):135-40. PubMed ID: 19041336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers.
    Sofuoglu M; Babb D; Hatsukami DK
    Nicotine Tob Res; 2003 Dec; 5(6):947-53. PubMed ID: 14668079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of smoking successive low- and high-nicotine cigarettes on hypothalamic-pituitary-adrenal axis hormones and mood in men.
    Mendelson JH; Goletiani N; Sholar MB; Siegel AJ; Mello NK
    Neuropsychopharmacology; 2008 Mar; 33(4):749-60. PubMed ID: 17507912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FKBP5 variation is associated with the acute and chronic effects of nicotine.
    Jensen KP; Herman AI; Morean ME; Kranzler HR; Gelernter J; Sofuoglu M
    Pharmacogenomics J; 2015 Aug; 15(4):340-6. PubMed ID: 25532758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
    Knott VJ; Fisher DJ
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):368-81. PubMed ID: 17696684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Facial EMG as an index of affective response to nicotine.
    Robinson JD; Cinciripini PM; Carter BL; Lam CY; Wetter DW
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):390-9. PubMed ID: 17696686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotine preference in smokers as a function of smoking abstinence.
    Perkins KA; Grobe JE; Weiss D; Fonte C; Caggiula A
    Pharmacol Biochem Behav; 1996 Oct; 55(2):257-63. PubMed ID: 8951962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166).
    Chausmer AL; Smith BJ; Kelly RY; Griffiths RR
    Behav Pharmacol; 2003 Mar; 14(2):111-20. PubMed ID: 12658071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.
    Winhusen TM; Somoza EC; Brigham GS; Liu DS; Green CA; Covey LS; Croghan IT; Adler LA; Weiss RD; Leimberger JD; Lewis DF; Dorer EM
    J Clin Psychiatry; 2010 Dec; 71(12):1680-8. PubMed ID: 20492837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subjective, physiological, and cognitive responses to intravenous nicotine: effects of sex and menstrual cycle phase.
    DeVito EE; Herman AI; Waters AJ; Valentine GW; Sofuoglu M
    Neuropsychopharmacology; 2014 May; 39(6):1431-40. PubMed ID: 24345818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.
    Jensen KP; DeVito EE; Herman AI; Valentine GW; Gelernter J; Sofuoglu M
    Neuropsychopharmacology; 2015 Nov; 40(12):2813-21. PubMed ID: 25948103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial.
    Hamidovic A; Khafaja M; Brandon V; Anderson J; Ray G; Allan AM; Burge MR
    Mol Psychiatry; 2017 Oct; 22(10):1413-1421. PubMed ID: 28242873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking cessation during alcohol treatment: a randomized trial of combination nicotine patch plus nicotine gum.
    Cooney NL; Cooney JL; Perry BL; Carbone M; Cohen EH; Steinberg HR; Pilkey DT; Sevarino K; Oncken CA; Litt MD
    Addiction; 2009 Sep; 104(9):1588-96. PubMed ID: 19549054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex and ovarian hormones influence vulnerability and motivation for nicotine during adolescence in rats.
    Lynch WJ
    Pharmacol Biochem Behav; 2009 Nov; 94(1):43-50. PubMed ID: 19619575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.